Socioeconomic disparities in surveillance and follow‐up of patients with thoracic aortic aneurysm
Shang M, Weininger G, Mori M, Kahler‐Quesada A, Degife E, Brooks C, Yousef S, Williams M, Assi R, Geirsson A, Vallabhajosyula P. Socioeconomic disparities in surveillance and follow‐up of patients with thoracic aortic aneurysm. Journal Of Cardiac Surgery 2021, 37: 831-839. PMID: 34873754, DOI: 10.1111/jocs.16173.Peer-Reviewed Original ResearchConceptsAortic aneurysmArea Deprivation IndexCardiovascular specialistsSocioeconomic statusSurgical interventionAneurysm sizeReferral of patientsRisk of deathSignificant risk factorsThoracic aortic aneurysmComputed tomography scanLowest socioeconomic quartileLow socioeconomic statusLower Socioeconomic StatusADI quartileAortic surveillanceAortic dissectionConsecutive patientsPrimary outcomeSpecialist referralSurgical repairTimely followSurveillance imagingRisk regressionRisk factorsRisk reduction and pharmacological strategies to prevent progression of aortic aneurysms
Weininger G, Chan SM, Zafar M, Ziganshin BA, Elefteriades JA. Risk reduction and pharmacological strategies to prevent progression of aortic aneurysms. Expert Review Of Cardiovascular Therapy 2021, 19: 619-631. PMID: 34102944, DOI: 10.1080/14779072.2021.1940958.Peer-Reviewed Original ResearchConceptsAortic aneurysmAbdominal aortic aneurysmß-blockersAngiotensin II receptor blockersAngiotensin-converting enzyme inhibitorAnti-platelet medicationDifferent pharmacologic therapiesII receptor blockersAortic aneurysm patientsThoracic aortic aneurysmRisk reductionAortic aneurysm growthPharmacologic managementReceptor blockersPharmacologic therapyMedical therapySurgical interventionAneurysm patientsMiscellaneous drugsAneurysm diseasePharmacological strategiesSyndrome patientsMarfan syndromeEnzyme inhibitorsAneurysms